[Tobramycin in the treatment of non-tubercular infectious bronchopneumopathies].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M Serembe.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
86% of 1703 subjects with primary malignant bronchopulmonary tumours treated over a period of 5 years responded solely to symptomatic management. Attention is drawn to the poor results offered by polychemotherapy and to satisfactory treatment of 82 patients with 6-methylprednisolone acetate. This drug was chosen on account of its ease of administration and fewer side-effects by comparison with cortisones given per os.
Explore the source record for details and available documents.
23 physicians in Italy took part in a multi-centre clinical trial of doxycycline in the treatment of respiratory tract infections. The case records of 290 patients were assessed with respect to both subjective and objective improvement and clinical cure: most patients were considered improved by the third day and cured by the fifth. The recommended dose of doxycycline was 200 mg on the first day and 100 mg daily thereafter; only 11 of the patients had to continue treatment beyond the tenth day. The antibiotic was extremely well tolerated; gastrointestinal side-effects occurred in 10 patients. Overall, 88.6% of the patients achieved a very good or good result.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.